Completed PHASE3 INTERVENTIONAL 2-arm NCT01485315

Transfusion-requirements in Septic Shock Trial (TRISS)

Effects of Red Blood Cell Transfusion on Mortality and Morbidity in Patients With Septic Shock

Sponsor: Copenhagen Trial Unit, Center for Clinical Intervention Research

Interventions SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion

Updated 6 times since 2017 Last updated: Oct 2, 2014 Started: Nov 30, 2011 Primary completion: Mar 31, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Septic Shock and is currently completed. Copenhagen Trial Unit, Center for Clinical Intervention Research leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Copenhagen Trial Unit, Center for Clinical Intervention Research
Rigshospitalet, Denmark
Scandinavian Critical Care Trials Group
University of Copenhagen

Data source: Scandinavian Critical Care Trials Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalborg, Denmark , Aarhus, Denmark , Bergen, Norway , Copenhagen, Denmark , Gentofte Municipality, Denmark , Halmstad, Sweden , Helsingborg, Sweden , Helsinki, Finland , Herning, Denmark , Hjørring, Denmark and 16 more locations